Role of lifestyle modification intervention and Triphala Kajjali tablet in the management of metabolic syndrome - A single blind randomized comparative clinical trial

IPGT AND RA Gujrat ayurved University Jamnagar0 个研究点目标入组 90 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•1.Patients having age between 20 Ã¢â?¬â?? 50 years of either sex
•2.Abdominal obesity, (waist circumference >102 cm in men and >88 cm in women)
•3.Hypertriglyceridemia (S. Triglycerides level 150-300 mg/dl)
•4.Low HDL cholesterol (S.HDL cholesterol <40 mg/dl for men and <50 mg/dl for women)
•5.Elevated blood pressure (Systolic blood pressure above 130mmHg and/or diastolic blood pressure above 85mmHg)
•6.Impaired fasting glucose (Fasting plasma glucose 100-125 mg/dl).

•1.Age below 20 and above 50 years.
•2.Drug-induced dyslipidemia.
•3.Systemic illness like Tuberculosis, Carcinoma and Endocrine disorders like Cushing
•syndrome, Hypothyroidism.
•4.Patient having the past history of M.I. & Unstable Angina.
•5.Patient having Clinical Features of CCF.
•6.Patients having a major renal or liver disorder.
•7.Patients having fasting blood sugar Ã¢â?°Â¥ 150 mg/dl.
•8.Patients taking allopathic treatment of Diabetes, Hypertension or Cholesterol.

发起方

IPGT AND RA Gujrat ayurved University Jamnagar